David J Maron MD

Summary

• Dr. David Maron is a preventive cardiologist on faculty at Stanford University. He completed Internal Medicine residency at UCLA David Geffen School of Medicine/UCLA Medical Center, a Robert Wood Johnson Clinical Scholars fellowship at Stanford, and Cardiovascular Disease fellowship at Stanford. He was on faculty at Vanderbilt for 20 years before returning to Stanford in 2014. He is the C.F. Rehnborg Professor of Medicine and Chief of the Stanford Prevention Research Center. Dr. Maron’s research is focused on the primary and secondary prevention of coronary artery disease. He was a member of the team that designed the VA-funded COURAGE trial that tested the benefit of PCI added to guideline-directed medical therapy in patients with stable coronary artery disease. He was co-chair and principal investigator of the ISCHEMIA trial, an NIH-funded study that tested the benefits of an invasive approach (cardiac catheterization and revascularization added to guideline-directed medical therapy) in patients with stable coronary artery disease. He is co-chair of the TRANSFORM trial comparing conventional risk factor-based care with atherosclerosis stage-based care in a high-risk asymptomatic population. He helped develop an AI algorithm to measure coronary artery calcium in chest CT scans performed for non-cardiac reasons (opportunistic screening). He then used the algorithm to test the impact of notifying statin-naïve patients and their doctors about the presence of incidental coronary calcification—including personalized images—and found a dramatic initiation of statin therapy. He is president-elect of the American Society for Preventive Cardiology.